Two-Year Outcomes From a Prospective Multicenter Investigation Device Trial of a Novel Conformal Mesh Interbody Fusion Device.

Chi, John H; Nunley, Pierce D; Huang, Kevin T; Krag, Martin H; Bydon, Mohamad; Lavoie, Stephane; Lu, Yi; Driver, Joseph; Stone, Marcus B

Chi, John H; Nunley, Pierce D; Huang, Kevin T; Krag, Martin H; Bydon, Mohamad; Lavoie, Stephane; Lu, Yi; Driver, Joseph; Stone, Marcus B.

Afiliação

Chi JH; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School.
Nunley PD; Spine Institute of Louisiana.
Huang KT; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School.
Krag MH; Department of Orthopedic Surgery, University of Vermont Medical Center.
Bydon M; Department of Neurosurgery, Mayo Clinic Hospital.
Lavoie S; Florida Orthopedic Associates.
Lu Y; Spine Institute of Louisiana.
Driver J; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School.
Stone MB; Spine Institute of Louisiana mstone@louisianaspine.org.

Int J Spine Surg ; 15(6): 1103-1114, 2021 Dec.

Article em En | MEDLINE | ID: mdl-35086867

Palavras-chave

FDA study; degenerative spondylolisthesis; investigational device exemption; lumbar interbody fusion; minimally invasive spine surgery; transforaminal lumbar interbody fusion

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article